# clm_6768B441C8E0

subject: Abbott Laboratories (/record/abbott-laboratories.md)  
predicate: quarterly_research_and_development  
value: 782,000,000 United States dollar  
valid_from: 2022-09-30  
valid_to: 2023-03-31  
published: 2022-11-01  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_602C8D08E319  
last_updated: 2026-11-08  
cite: AsOf. "Abbott Laboratories quarterly research and development: 782,000,000 United States dollar", as of 2022-09-30 (until 2023-03-31). Claim clm_6768B441C8E0, https://asof.is/claim/clm_6768B441C8E0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1800/000162828022027550/0001628280-22-027550-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2022, filed 2022-11-01  

## Sources

- https://www.sec.gov/Archives/edgar/data/1800/000162828022027550/0001628280-22-027550-index.htm (primary, SEC EDGAR 10-Q Q3 FY2022, published 2022-11-01)

## Supersedes

- [Abbott Laboratories](/record/abbott-laboratories.md) | quarterly_research_and_development | 684,000,000 United States dollar | valid 2022-06-30 to 2022-09-30 | conf 0.95 | superseded | superseded_by [clm_6768B441C8E0](/claim/clm_6768B441C8E0.md) | [clm_D0D6418B59F7](/claim/clm_D0D6418B59F7.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.